Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

被引:122
|
作者
Dai, Cong [1 ]
Jiang, Min [1 ]
Sun, Ming-Jun [1 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 05期
关键词
D O I
10.1056/NEJMc1707500
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:496 / 496
页数:1
相关论文
共 50 条
  • [1] Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
    Sandborn, William J.
    Su, Chinyu
    Sands, Bruce E.
    D'Haens, Geert R.
    Vermeire, Severine
    Schreiber, Stefan
    Danese, Silvio
    Feagan, Brian G.
    Reinisch, Walter
    Niezychowski, Wojciech
    Friedman, Gary
    Lawendy, Nervin
    Yu, Dahong
    Woodworth, Deborah
    Mukherjee, Arnab
    Zhang, Haiying
    Healey, Paul
    Panes, Julian
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1723 - 1736
  • [2] Tofacitinib for the induction and maintenance of medically resistant ulcerative colitis
    Weisshof, R.
    Golan, M. Aharoni
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S404 - S404
  • [3] Ulcerative colitis: Induction Therapy effective with Tofacitinib
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (05): : 556 - 556
  • [4] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [5] TOFACITINIB FOR THE INDUCTION AND MAINTENANCE OF MEDICALLY-RESISTANT ULCERATIVE COLITIS
    Weisshof, Roni
    Golan, Maya Aharoni
    Rubin, David T.
    GASTROENTEROLOGY, 2018, 154 (06) : S376 - S376
  • [6] Tofacitinib induction therapy in ulcerative colitis can be prolonged
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (12): : 1742 - +
  • [7] Rapid Onset of Tofacitinib Induction Therapy for the Treatment of Ulcerative Colitis
    Griller, Nadia
    Cohen, Lawrence
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) : 1213 - 1213
  • [8] Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    D'Haens, Geert
    Dubinsky, Marla
    Kobayashi, Taku
    Irving, Peter M.
    Howaldt, Stefanie
    Pokrotnieks, Juris
    Krueger, Kathryn
    Laskowski, Janelle
    Li, Xingyuan
    Lissoos, Trevor
    Milata, Joe
    Morris, Nathan
    Arora, Vipin
    Milch, Catherine
    Sandborn, William
    Sands, Bruce E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (26): : 2444 - 2455
  • [9] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Sands, B. E.
    Sandborn, W. J.
    Panaccione, R.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Adedokun, O. J.
    Li, K.
    Peyrin-Biroulet, L.
    Van Assche, G.
    Danese, S.
    Targan, S.
    Abreu, M. T.
    Hisamatsu, T.
    Szapary, P.
    Marano, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1201 - 1214
  • [10] Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Feagan, Brian G.
    Rutgeerts, Paul
    Sands, Bruce E.
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sandborn, William J.
    Van Assche, Gert
    Axler, Jeffrey
    Kim, Hyo-Jong
    Danese, Silvio
    Fox, Irving
    Milch, Catherine
    Sankoh, Serap
    Wyant, Tim
    Xu, Jing
    Parikh, Asit
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 699 - 710